ELENA YURENEVA, Executive Director, Head of Medical Safety and Risk Management, Alnylam Pharmaceuticals

Elena Yureneva, MD, MHA currently serves as an Executive Director at Alnylam Global Patient Safety and Risk Management department, Head of Medical Safety and Risk Management. Dr. Yureneva acquired her MD at the First Moscow State Medical University in Russia and specialized in cardiology. She acquired her Master’s Degree in Health Systems Administration at Georgetown University. Prior to pursuing her career in pharmaceutical industry, she served as a Chief of Staff to the Chief Medical Officer at Children’s National Health Systems in Washington, DC. Dr Yureneva has 9 years of pharmacovigilance experience from Alnylam, Merck and Cubist.